Showing results (2611-2620 of 2,777) with videos related to

Sort By:
Pageof 278
The New England Journal of Medicine|April 30, 2004
Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infectionRoy M Gulick, Heather J Ribaudo, Cecilia M Shikuma, et al.
African Health Sciences|November 3, 2025
Seroprevalence of anti-SARS-CoV-2 IgG antibodies among vaccinated healthcare workers in Bamako, MaliEtienne Dembele, Yacouba Cissoko, Anou M Somboro, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2013
Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs)Swati P Mercer, Anthony J Roecker, Susan Garson, et al.
Transfusion|November 9, 2018
Intradonor reproducibility and changes in hemolytic variables during red blood cell storage: results of recall phase of the REDS-III RBC-Omics studyMarion C Lanteri, Tamir Kanias, Sheila Keating, et al.
HIV Clinical Trials|October 9, 2001
Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: a randomized controlled trialJ P Lalezari, J A Beal, P J Ruane, et al.
Journal of Medicinal Chemistry|June 17, 2008
2-Aminobenzophenones as a novel class of bradykinin B1 receptor antagonistsDai-Shi Su, John L Lim, Elizabeth Tinney, et al.
Plos One|March 6, 2023
Hepatocellular carcinoma presentation and prognosis among Nigerian adults with and without HIVPantong M Davwar, Edith Okeke, Mary Duguru, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2008
Proline bis-amides as potent dual orexin receptor antagonistsJeffrey M Bergman, Anthony J Roecker, Swati P Mercer, et al.
The Journal of Infectious Diseases|February 28, 2002
Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patientsConstance A Benson, Steven G Deeks, Scott C Brun, et al.
Annals of Surgical Oncology|August 3, 2017
A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive DiseaseJames W Jakub, Brittany L Murphy, Alexandra B Gonzalez, et al.
Pageof 278